Stocks: European shares were advancing Tuesday, boosted by a long-awaited trade deal between the EU and India. The free-trade agreement is the biggest either side h ...
The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results